Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Isabel Fegers-Wustrow"'
Autor:
Stephan Mueller, Bernhard Haller, Anna Feuerstein, Ephraim B. Winzer, Paul Beckers, Mark J. Haykowsky, Andreas B. Gevaert, Jennifer Hommel, Luciene F. Azevedo, André Duvinage, Katrin Esefeld, Isabel Fegers‐Wustrow, Jeffrey W. Christle, Elisabeth Pieske‐Kraigher, Evgeny Belyavskiy, Daniel A. Morris, Martin Kropf, Radhakrishnan Aravind‐Kumar, Frank Edelmann, Axel Linke, Volker Adams, Emeline M. Van Craenenbroeck, Burkert Pieske, Martin Halle, the OptimEx‐Clin Study Group
Publikováno v:
ESC Heart Failure, Vol 9, Iss 5, Pp 3393-3406 (2022)
Abstract Aims Exercise training (ET) has been consistently shown to increase peak oxygen consumption (V̇O2) in patients with heart failure with preserved ejection fraction (HFpEF); however, inter‐individual responses vary significantly. Because it
Externí odkaz:
https://doaj.org/article/159531c046df4b9b9534243596bb7364
Autor:
Wesley J. Tucker, Isabel Fegers-Wustrow, Martin Halle, Mark J. Haykowsky, Eugene H. Chung, Jason C. Kovacic
Publikováno v:
Journal of the American College of Cardiology. 80:1091-1106
Publikováno v:
Journal of the American College of Cardiology. 79:1304-1313
Publikováno v:
Herz. 47:55-62
Autor:
Dario Bongiovanni, Nina Schreiner, Rosanna Gosetti, Katharina Mayer, Dominick J. Angiolillo, Dirk Sibbing, Stefan Holdenrieder, Aida Anetsberger, Moritz von Scheidt, Heribert Schunkert, Karl-Ludwig Laugwitz, Stefanie Schüpke, Adnan Kastrati, Isabel Fegers-Wustrow, Isabell Bernlochner
Publikováno v:
Arteriosclerosis, Thrombosis, and Vascular Biology. 43
Background: Immature or reticulated platelets are associated with impaired efficacy of antiplatelet drugs and adverse events in cardiovascular patients. Their role as a predictive biomarker in patients with acute coronary syndrome treated with potent
Publikováno v:
Klinische Kardiologie ISBN: 9783662629390
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e04c320a72ce278edb15ba93d1666af9
https://doi.org/10.1007/978-3-662-62939-0_38-1
https://doi.org/10.1007/978-3-662-62939-0_38-1
Publikováno v:
HerzLiteratur. 47(1)
This article summarizes the innovations and most important points of the recently published and updated ESC guidelines 2021 on the prevention of cardiovascular diseases. Developments in risk stratification and further developments with respect to tar
Publikováno v:
Journal of the American College of Cardiology. 79(13)
This review compares the primary prevention recommendations of the recent 2021 European Society of Cardiology (ESC) and 2019 American College of Cardiology (ACC)/American Heart Association (AHA) guidelines on cardiovascular disease (CVD) prevention.
Autor:
Sophia MT Dinges, Janosch Krotz, Felix Gass, Julian Treitschke, Isabel Fegers-Wustrow, Marisa Geisberger, Katrin Esefeld, Pia von Korn, André Duvinage, Frank Edelmann, Oliver Wolfram, Julia Brandts, Ephraim B Winzer, Bernd Wolfarth, Felix Freigang, Sarah Neubauer, Thomas Nebling, Björn Hackenberg, Volker Amelung, Stephan Mueller, Martin Halle
Publikováno v:
Diabetes & vascular disease research 19(4), (2022). doi:10.1177/14791641221113781
Diabetes & vascular disease research 19(4), (2022). doi:10.1177/14791641221113781
Published by Sage, London
Published by Sage, London
Autor:
Jan Daniel Niederdöckl, Alexander Simon, Nina Buchtele, Nikola Schütz, Filippo Cacioppo, Julia Oppenauer, Sophie Gupta, Martin Lutnik, Sebastian Schnaubelt, Alexander Spiel, Dominik Roth, Fritz Wimbauer, Isabel Fegers-Wustrow, Katrin Esefeld, Martin Halle, Jürgen Scharhag, Thomas Laschitz, Harald Herkner, Hans Domanovits, Michael Schwameis
Publikováno v:
Journal of Personalized Medicine; Volume 12; Issue 4; Pages: 544
Background: Modern personalised medicine requires patient-tailored decisions. This is particularly important when considering pharmacological cardioversion for the acute treatment of haemodynamically stable atrial fibrillation and atrial flutter in a